No Data
Muromachi Chemicals --- In the second quarter, there was a double-digit increase in profit, with both the health food business and Chemicals business achieving increased revenue.
Muromachi Chemical <4885> announced its financial results for the second quarter of the fiscal year ending May 2025 (June-November 2024) on the 14th. Revenue increased by 1.8% year-on-year to 2.965 billion yen, operating profit increased by 34.0% to 0.154 billion yen, ordinary profit increased by 55.4% to 0.171 billion yen, and interim net profit increased by 29.5% to 0.12 billion yen. In the Pharmaceutical Business, revenue decreased by 11.3% year-on-year to 1.352 billion yen, and operating profit decreased by 16.0% to 0.166 billion yen. Import raw materials are,
Toho's operating profit in the third quarter increased by 26.9% to 52.8 billion yen.
Toho <9602> announced that for the third quarter of the fiscal period ending February 2025, operating revenue increased by 15.3% year-on-year to 234.169 billion yen, and operating profit rose by 26.9% to 52.81 billion yen. The film exhibition business saw a decrease in both revenue and profit compared to the previous year, but the sales of character goods related to Toho's monster characters, centered around 'Godzilla,' significantly contributed to operating income. 【Positive evaluation】 <3266> FundクリG full year | <9837> Morito full year <4413> Board
Muromachi Chemicals: Confirmation
Muromachi Chemicals: Presentation of financial results for the 2nd quarter of the fiscal year ending May 2025
Muromachi Chemicals: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/5 [Japanese GAAP] (unconsolidated)
Muromachi Chemicals: Half Year Report - Term 79 (2024/06/01 - 2025/05/31)